GAO Report On Part D May Dampen Congressional Enthusiasm For POS Rebates

 
• By Cathy Kelly

Legislation redirecting manufacturer rebates on prescription drugs to the point of sale could face an uphill battle following report’s description of the way rebates lower costs in Medicare Part D.

A person holding an umbrella in the rain. - Image
Support For POS Rebates Slipping Away?

More from Pricing Debate

More from Market Access